Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard H Bailey

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Cancer Chemotherapy and Pharmacology|September 22, 2007
Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancerHoward H Bailey, Steven Attia, Richard R Love, et al.
Gynecologic Oncology|January 30, 2007
Weekly docetaxel and carboplatin for recurrent ovarian and peritoneal cancer: a phase II trialDavid M Kushner, Joseph P Connor, Federico Sanchez, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2002
Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridolJames P Thomas, Kendra D Tutsch, James F Cleary, et al.
Cancer Investigation|March 23, 2005
Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network StudyBrad S Kahl, Howard H Bailey, Eileen P Smith, et al.
Leukemia & Lymphoma|August 26, 2011
Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology NetworkVaishalee P Kenkre, Walter L Long, Jens C Eickhoff, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 23, 2015
Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast CancerCarol J Fabian, Bruce F Kimler, Carola M Zalles, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 20, 2014
Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancerJill M Kolesar, Marcia Pomplun, Tom Havighurst, et al.
Cancer Chemotherapy and Pharmacology|June 19, 2004
A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 daysHoward H Bailey, George Wilding, Kendra D Tutsch, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2013
Vorinostat in combination with bortezomib in patients with advanced malignancies directly alters transcription of target genesJill M Kolesar, Anne M Traynor, Kyle D Holen, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 28, 2015
Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomyJason R Gee, Daniel R Saltzstein, Edward Messing, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|September 22, 2007
Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancerHoward H Bailey, Steven Attia, Richard R Love, et al.
Gynecologic Oncology|January 30, 2007
Weekly docetaxel and carboplatin for recurrent ovarian and peritoneal cancer: a phase II trialDavid M Kushner, Joseph P Connor, Federico Sanchez, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2002
Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridolJames P Thomas, Kendra D Tutsch, James F Cleary, et al.
Cancer Investigation|March 23, 2005
Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network StudyBrad S Kahl, Howard H Bailey, Eileen P Smith, et al.
Leukemia & Lymphoma|August 26, 2011
Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology NetworkVaishalee P Kenkre, Walter L Long, Jens C Eickhoff, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 23, 2015
Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast CancerCarol J Fabian, Bruce F Kimler, Carola M Zalles, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 20, 2014
Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancerJill M Kolesar, Marcia Pomplun, Tom Havighurst, et al.
Cancer Chemotherapy and Pharmacology|June 19, 2004
A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 daysHoward H Bailey, George Wilding, Kendra D Tutsch, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2013
Vorinostat in combination with bortezomib in patients with advanced malignancies directly alters transcription of target genesJill M Kolesar, Anne M Traynor, Kyle D Holen, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 28, 2015
Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomyJason R Gee, Daniel R Saltzstein, Edward Messing, et al.
Pageof 6